Gladius Capital Management LP Boston Scientific Corp Transaction History

Gladius Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$38.58 - $44.24 $6,365 - $7,299	-165 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $50,153 - $56,410	-1,422 Reduced 89.6%	165 $7,000
Q4 2020 Feb 09, 2021	BUY	$33.15 - $41.97 $16,873 - $21,362	509 Added 47.22%	1,587 $58,000
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $37,126 - $45,523	1,078 New	1,078 $42,000

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.